We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
-2.79%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$3.17B
AUM Growth
-$346M
Cap. Flow
-$139M
Cap. Flow %
-4.39%
Top 10 Hldgs %
44.56%
Holding
148
New
26
Increased
24
Reduced
52
Closed
18

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$22.1M
2
SMLR
Semler Scientific
SMLR
+$18.4M
3
TSHA icon
Taysha Gene Therapies
TSHA
+$15.5M
4
FTCV
FinTech Acquisition Corp. V Class A Common Stock
FTCV
+$10.5M
5
IMAX icon
IMAX
IMAX
+$10.4M

Top Sells

Rank Stock Value
1
VG
Vonage Holdings Corporation
VG
+$18.9M
2
LNW
Light & Wonder
LNW
+$15.3M
3
PWP icon
Perella Weinberg Partners
PWP
+$13.7M
4
FTCVU
FinTech Acquisition Corp. V Unit
FTCVU
+$13.1M
5
PAYO icon
Payoneer
PAYO
+$11.2M

Sector Composition

Rank Sector Weight
1 Healthcare 24.07%
2 Consumer Discretionary 8.35%
3 Technology 4.89%
4 Financials 4.19%
5 Communication Services 4.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBQ
51
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
$15.1M 0.48%
1,000,000
– –
DRIO icon
52
DarioHealth
DRIO
$74.7M
$14.5M 0.46%
53,176
– –
AKBA icon
53
Akebia Therapeutics
AKBA
$234M
$14.3M 0.45%
4,978,195
-191,868
-4% -$548K
EXAS
54
PUT
DELISTED
Exact Sciences
EXAS
$14.3M 0.45%
150,000
+50,000
+50% +$5.28M
TDOC icon
55
PUT
Teladoc Health
TDOC
$1.29B
$12.7M 0.4%
100,000
-140,000
-58% -$20.4M
SPRY icon
56
ARS Pharmaceuticals
SPRY
$587M
$12.2M 0.39%
1,226,631
-39,635
-3% -$977K
SYRE icon
57
Spyre Therapeutics
SYRE
$9.29B
$12.1M 0.38%
60,678
-6,403
-10% -$1.12M
HLF icon
58
CALL
Herbalife
HLF
$1.21B
$11.8M 0.37%
278,000
– –
STR
59
DELISTED
Sitio Royalties
STR
$11.7M 0.37%
623,728
-32,959
-5% -$615K
SPCE icon
60
CALL
Virgin Galactic
SPCE
$489M
$10.1M 0.32%
20,000
– –
FTCV
61
DELISTED
FinTech Acquisition Corp. V Class A Common Stock
FTCV
$10M 0.32%
+991,432
New +$10.5M
FTVIU
62
DELISTED
FinTech Acquisition Corp. VI Units
FTVIU
$10M 0.32%
1,000,000
– –
GYRE icon
63
Gyre Therapeutics
GYRE
$713M
$10M 0.32%
324,295
-13,220
-4% -$435K
ARYE
64
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$9.88M 0.31%
+1,000,000
New +$9.93M
IIII
65
DELISTED
INSU Acquisition Corp. III Class A Common Stock
IIII
$9.82M 0.31%
+999,996
New +$9.74M
HERA
66
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
$9.74M 0.31%
+999,991
New +$9.75M
LINC icon
67
Lincoln Educational Services
LINC
$976M
$9.6M 0.3%
1,434,674
-23,534
-2% -$158K
SLNO
68
DELISTED
Soleno Therapeutics
SLNO
$9.03M 0.28%
651,009
– –
HCA icon
69
HCA Healthcare
HCA
$89.6B
$8.64M 0.27%
35,600
– –
SRL icon
70
Scully Royalty
SRL
$89.4M
$8.54M 0.27%
752,434
-26,915
-3% -$343K
SSKN
71
DELISTED
Strata Skin Sciences
SSKN
$8.42M 0.27%
457,581
-810
-0.2% -$12.4K
VMD icon
72
Viemed Healthcare
VMD
$355M
$7.95M 0.25%
1,433,201
-267,395
-16% -$1.74M
ZGNX
73
DELISTED
Zogenix, Inc.
ZGNX
$7.32M 0.23%
481,782
+95,086
+25% +$1.49M
ZVO
74
DELISTED
Zovio Inc. Common Stock
ZVO
$7.17M 0.23%
3,001,190
-140,096
-4% -$346K
PRTY
75
CALL
DELISTED
Party City Holdco Inc.
PRTY
$7.1M 0.22%
1,000,000
– –
1 2
3
4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Nantahala Capital Management held 148 positions worth $3.17B, down 9.8% from $3.52B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Nantahala Capital Management withdrew a net $139M in Q3 2021, closing 18 positions and reducing 52 holdings. Its most notable exit was FinTech Acquisition Corp. V Unit, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Nantahala Capital Management opened a new position in iShares Russell 2000 ETF worth $21.8M.

  • Nantahala Capital Management's largest Q3 2021 buy was iShares Russell 2000 ETF: 99,593 shares worth $21.8M.
  • Nantahala Capital Management added most to Taysha Gene Therapies in Q3 2021, an estimated $15.5M increase.
  • Nantahala Capital Management's biggest Q3 2021 reduction was Vonage Holdings Corporation, cutting an estimated $18.9M.
  • Nantahala Capital Management fully exited FinTech Acquisition Corp. V Unit in Q3 2021, selling an estimated $13.1M.
  • Nantahala Capital Management's ten largest holdings make up 45% of its $3.17B portfolio in Q3 2021.
  • Nantahala Capital Management opened 26 new positions and closed 18 in Q3 2021.
  • Nantahala Capital Management's portfolio value fell 9.8% quarter-over-quarter to $3.17B.

Based on Nantahala Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.